U.S. chip giant Nvidia said on Monday it is building Britain’s most powerful supercomputer, which will use artificial intelligence to help researchers solve pressing medical challenges, including those related to COVID-19. GSK and AstraZeneca, which are both involved in coronavirus vaccine research, will be two of the first pharmaceutical companies to harness the power of the machine, Nvidia said. The Cambridge-1 computer, which is expected to come online by the end of the year in Cambridge, east England, will be a NVIDIA DGX SuperPOD system capable of delivering more than 400 petaflops of AI performance, the company said.,
U.S. chip giant Nvidia said on Monday it is building Britain’s most powerful supercomputer, which will use artificial intelligence to help researchers solve pressing medical challenges, including those related to COVID-19. GSK and AstraZeneca, which are both involved in coronavirus vaccine research, will be two of the first pharmaceutical companies to harness the power of the machine, Nvidia said. The Cambridge-1 computer, which is expected to come online by the end of the year in Cambridge, east England, will be a NVIDIA DGX SuperPOD system capable of delivering more than 400 petaflops of AI performance, the company said.
,